Vedolizumab and ustekinumab levels in pregnant women with inflammatory bowel disease and infants exposed in-utero.
Prentice R, Flanagan E, Wright EK, Gibson PR, Rosella S, Rosella O, Begun J, An YK, Lawrance IC, Kamm MA, Sparrow M, Goldberg R, Prideaux L, Vogrin S, Kiburg KV, Ross AL, Burns M, Bell SJ.
Prentice R, et al. Among authors: bell sj.
Clin Gastroenterol Hepatol. 2024 Mar 14:S1542-3565(24)00252-0. doi: 10.1016/j.cgh.2024.02.025. Online ahead of print.
Clin Gastroenterol Hepatol. 2024.
PMID: 38492905